5-(5-(2-CHLOROETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)-2-(HYDROXYMETHYL)OXOLAN-3-YL 2-(DIMETHOXYPHOSPHORYL)ACETATE, (2R,3S,5R)-
UNII LV3E342PMH
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(5-(2-chloroethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 2-(dimethoxyphosphoryl)acetate, (2r,3s,5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LV3E342PMH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 115365-38-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H22ClN2O9P ADNKTJWFVBALEW-QJPTWQEYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(5-(2-chloroethyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 2-(dimethoxyphosphoryl)acetate, (2r,3s,5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.